New cancer patients — especially Black people — are more susceptible to severe Covid-19 infections
Recently diagnosed cancer patients are more vulnerable to Covid-19 infection and face more severe illness…
Category: coronavirus
Opinion: New data, dashboard provide information on Covid-19 hospital capacity
The surge in Covid-19 cases that began in early November has raised questions about how…
Opinion: Engage ‘willing skeptics’ to help increase Covid-19 vaccination rates
More than 250,000 people in the U.S. alone have died from Covid-19 this year. Researchers…
Tracking the FDA advisory panel meeting on the Pfizer/BioNTech Covid-19 vaccine
A panel of outside experts is meeting Thursday to consider whether the Food and Drug…
Covid-19 surge could lead to another drop in patient visits, doctors fear — and more missed pediatric cancers
Nothing prepares a parent for a child’s cancer diagnosis. Even more unthinkable is wondering if…
Johnson & Johnson cuts size of Covid-19 vaccine study due to prevalence of disease in U.S.
Johnson & Johnson is cutting the size of its pivotal U.S. Covid-19 vaccine trial —…
Opinion: To defeat Covid-19, we must acknowledge the fear it engenders
My career as a hospital epidemiologist has been based on science and evidence, which I…
Opinion: FDA: Leave the door open to Covid-19 vaccination for pregnant and lactating health workers
On Thursday, the FDA will review the near-term fate of the Pfizer/BioNtech Covid-19 vaccine. It…
STAT+: ‘Why would we ever go back?’: Covid-driven shift to remote cancer clinical trials will likely outlast the pandemic
The coronavirus pandemic has presented an extreme challenge for cancer clinical trials, with many shutting…
Drive-by burials and FaceTime farewells: Grief in the Covid era will weigh on the American psyche for years to come
The rituals of grief and mourning are as old as time: the swift Jewish burial…
Trump takes vaccine victory lap at White House summit
President Trump on Tuesday took a victory lap at a White House “Summit” meant to…
Detailed data on AstraZeneca-Oxford Covid-19 vaccine show it has moderate efficacy
The Covid-19 vaccine being developed by the University of Oxford and AstraZeneca appears to have…
FDA scientists endorse ‘highly effective’ Pfizer/BioNTech Covid-19 vaccine ahead of key panel
Scientists at the Food and Drug Administration endorsed the efficacy and safety of the Covid-19…
Biden’s health picks signal a bottom-up approach to the Covid-19 pandemic
President-elect Biden’s pandemic-response strategy took clearer shape this week with the rollout of several surprising…
Biden’s CDC pick, a savvy communicator, will take over at a time when agency’s voice has been muted
When Rochelle Walensky, head of infectious diseases at Massachusetts General Hospital, walks into the Centers…
Leading Covid-19 vaccine makers Pfizer and Moderna decline invitations to White House ‘Vaccine Summit’
Both Pfizer and Moderna, the two major drug manufacturers likely to receive emergency authorizations for…
.jpg)
Opinion: A new rule that protects VA clinicians who practice across state lines should kick off a movement
Amid the pandemonium of a turbulent election and a resurgent virus, the Department of Veterans…
Opinion: Covid-19 vaccine safety and the public trust: lessons from Paul Meier and polio
Early results of the Covid-19 vaccine trials sponsored by Pfizer, Moderna, and AstraZeneca are welcome…
On the ground, the pledge to vaccinate 20 million against Covid-19 in December seems unrealistic
Hospitals across the United States are preparing for a Covid-19 vaccine distribution timeline that’s well…
Opinion: Women’s perspectives and voices need more inclusion in Covid-19 media coverage
As media coverage of Covid-19 continues 24/7, it routinely ignores an important dimension of the…
How key decisions slowed FDA’s review of Covid-19 vaccine — but also gave it important data
In September, as Pfizer and partner BioNTech were quickly advancing a study of their Covid-19…
AstraZeneca’s confusing vaccine data, biotech in 2021, and a guide to the ASH conference
Can too much Covid-19 vaccine be a bad thing? Is biotech in a bubble? And…
CDC advisory panel’s lone dissenter on why long-term care residents shouldn’t receive Covid-19 vaccine first
When a Centers for Disease Control and Prevention advisory committee voted Tuesday to recommend residents…
Opinion: Extending health care to all ethically and practically: lessons from Covid-19
The long-standing debate over whether health care is a right or a privilege seems particularly…
.jpg)
Opinion: A better way to roll out Covid-19 vaccines: Vaccinate everyone in several hot zones
Dear CEOs of Pfizer, Moderna, and AstraZeneca, Thank you for rapidly mobilizing your scientific resources…
Opinion: Make science bipartisan again
The Biden-Harris administration faces daunting challenges. Chief among them is tackling the Covid-19 pandemic and…
‘There absolutely will be a black market’: How the rich and privileged can skip the line for Covid-19 vaccines
Bill Lang didn’t get much of a break over Thanksgiving. Almost every day last week,…
U.K. approves Pfizer’s Covid-19 vaccine, putting pressure on FDA
The United Kingdom on Wednesday became the first country to approve a Covid-19 vaccine developed…
Opinion: Better collection, reporting of race and ethnicity data are essential for fighting Covid-19
This year has challenged Americans to confront their understanding of society and to start rewriting…
The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them
It appears science may have found the Covid-19 pandemic’s off-ramp. Two vaccines developed with stunning…
Health workers, long-term care facilities should get Covid-19 vaccine first, CDC advisory panel says
A committee that advises the Centers for Disease Prevention and Control voted overwhelmingly on Tuesday…
How nanotechnology helps mRNA Covid-19 vaccines work
While the first two Covid-19 vaccines relying on messenger RNA technology speed toward regulatory approval…
White House to host Covid-19 vaccine summit, as Trump seeks to burnish record
The Trump administration has invited leading vaccine manufacturers, drug distributors, and government officials to a…
The PPE crisis didn’t go away: Across the U.S., grassroots supply networks are trying to fill the void
Christine Garcia was scrambling. As the San Francisco regional director at an agency for children…
Moderna to submit Covid-19 vaccine to FDA as full results show 94% efficacy
Moderna said Monday that its Covid-19 vaccine continued to deliver strong efficacy results, showing 94%…
Divisions emerge among U.S. officials over when first Covid-19 vaccine doses will be available — and for whom
Divisions are emerging among top U.S. officials over when the country’s first Covid-19 vaccine will…
Opinion: Every state needs emergency regulations to protect essential food workers
The darkest days of the pandemic are still ahead of us, as we head into…
STAT+: ‘How are we going to get on that plane?’: The transatlantic race to deliver CAR-T cancer therapy during the pandemic
On the evening that would jolt the global traffic of cancer treatments, David Kim was…
How much did Thanksgiving contribute to Covid-19 spread? It’s wait and see for now
And now we wait. Thanksgiving is over, and public health officials’ persistent warnings that large…
Opinion: I worked hard to protect myself from Covid-19 and the flu. Yet I got both — at the same time
My painful excursion into the world of dueling infections started on a Tuesday afternoon with…
Mask defiance remains strong in Big Sky Country, even as the pandemic rages
A cancer survivor vulnerable to serious illness, Chany Reon worried as the coronavirus swept through…
Opinion: Add Covid-related myocarditis, mechanical ventilation, and death to this year’s football risks
Our fourth annual Football Injury Highlight Reel is taking a different tack this year. In…
Opinion: What the biopharma industry is doing to build confidence in Covid-19 vaccines
Over the last few weeks, the United States has surpassed 100,000 Covid-19 cases a day…
Opinion: Beyond burnout: For health care workers, this surge of Covid-19 is bringing burnover
Covid-19 is roaring back for a third wave. The first two substantially increased feelings of…
A ‘bad case of déjà vu’: New Jersey hospitals brace for Covid-19 surge, but hope this time will be different
The first round of treating Covid-19 patients in New Jersey was brutal. Victorine Long Njaka,…
Opinion: OSHA’s ‘absurd reinterpretation’ of a regulation regarding workers and Covid-19
Workplace exposures continue to be a major driver of the coronavirus pandemic, something that the…
‘Essential workers’ likely to get earlier access to Covid-19 vaccine
Essential workers are likely to move ahead of adults 65 and older and people with…
AstraZeneca Covid-19 vaccine is 70% effective on average, early data show
AstraZeneca said Monday that its coronavirus vaccine reduced the risk of Covid-19 infection by an…
Opinion: Glaring omission from Biden’s Covid-19 task force: mental health expertise
The unprecedented spike in depression and anxiety that has accompanied the coronavirus pandemic points to…
Data show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains
Patients hospitalized with Covid-19 are surviving at higher rates than in the early days of…